BTC 
ETH 
BNB 
XRP 
SOL 
TRX Hims stock rises after RFK Jr. eases access to unapproved peptides
Investor's Business Daily reported that Hims stock surged on Wednesday after RFK Jr. circumvented the FDA to give a green light to some unapproved peptides. The post attributes the stock move to that easing of access.
Why “Unverified”
- Reported by Investor's Business Daily alone, with no second source or primary confirmation yet
1 independent source group across 1 post · evidence score 52/100. How labels work
What the sources claim
-
Hims stock jumped on Wednesday after RFK Jr. bypassed the FDA to allow some unapproved peptides.
“Hims stock popped Wednesday after RFK Jr. circumvented the FDA, giving a green light to some unapproved peptides.”
Investor's Business Daily
Sources
More in Stocks & Indices
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-10-28 17:40 UTC. Labels are computed from the sources, not by the model.